4D Molecular Therapeutics Inc. (FDMT) Social Stream



4D Molecular Therapeutics Inc. (FDMT): $24.41

0.34 (+1.41%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add FDMT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#215 of 354

in industry

4D MOLECULAR THERAPEUTICS INC (FDMT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering FDMT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-10 2 $70 $45 $57.5 $18.8 205.85%
2022-01-04 3 $45 $30 $37.5 $18.8 99.47%
2022-03-29 2 $42 $30 $36 $18.8 91.49%
2022-04-04 2 $37 $30 $33.5 $18.8 78.19%
2022-05-12 2 $37 $28 $32.5 $18.8 72.87%
2022-05-27 2 $28 $15 $21.5 $18.8 14.36%
2022-06-22 3 $28 $15 $21.666 $18.8 15.24%
2022-08-13 3 $28 $15 $21.666 $18.8 15.24%
2022-09-17 3 $22 $12 $16.333 $18.8 -13.12%
2022-10-27 3 $22 $10 $15.666 $18.8 -16.67%
2022-11-11 3 $22 $11 $16 $18.8 -14.89%
2022-11-14 4 $45 $11 $23.25 $18.8 23.67%
2022-11-15 4 $68.001 $15 $35 $18.8 86.17%
2022-11-21 5 $68.001 $15 $35.166 $18.8 87.05%
2023-01-25 5 $68.001 $15 $36 $18.8 91.49%
2023-02-03 6 $68.001 $15 $38 $18.8 102.13%
2023-02-08 6 $68.001 $14 $37.571 $18.8 99.85%
2023-03-27 6 $68.001 $14 $37.857 $18.8 101.37%
2023-04-27 6 $68.001 $13 $37.714 $18.8 100.61%
2023-05-05 6 $68.001 $22 $39 $18.8 107.45%
2023-05-11 6 $68.001 $21 $38.857 $18.8 106.69%
2023-06-06 6 $68.001 $23 $39.143 $18.8 108.21%
2023-06-07 6 $68.001 $23 $39.857 $18.8 112.01%
2023-06-08 7 $68.001 $23 $40.571 $18.8 115.8%
2023-07-05 7 $68.001 $23 $39.25 $18.8 108.78%
2023-07-11 7 $68.001 $24 $39.5 $18.8 110.11%
2023-08-14 7 $68.001 $22 $39.25 $18.8 108.78%
2023-10-19 8 $68.001 $24 $39.5 $18.8 110.11%
2023-10-25 8 $68.001 $24 $38.666 $18.8 105.67%
2023-10-30 8 $68.001 $25 $38.777 $18.8 106.26%
2023-11-10 9 $63 $25 $36.9 $18.8 96.28%
2023-11-13 9 $63 $25 $36.5 $18.8 94.15%

The Trend in the Analyst Price Target


FDMT's average price target has moved up $13.89 over the prior 17 months.

FDMT reports an average of 154.32% for its upside potential over the past 42 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-08 6 68.001 14 37.571 20.54 82.92%
2023-04-13 6 68.001 13 37.714 16.85 123.82%
2023-06-06 6 68.001 23 39.143 19.22 103.66%
2023-06-08 7 68.001 23 40.571 19.52 107.84%
2023-11-10 9 63.000 25 36.900 11.05 233.94%

FDMT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.11 8 1 0 0 0 9

The Trend in the Broker Recommendations


FDMT's average broker recommendation rating improved by 0.39 over the prior 52 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for FDMT as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, 4D MOLECULAR THERAPEUTICS INC's variance in analysts' estimates is lower than -3207.39% of them.
  • In terms of how 4D MOLECULAR THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 2282.65% of that group.
  • In the context of stocks in the small market cap category, 4D MOLECULAR THERAPEUTICS INC's average analyst price target is higher than 3190.6% of them.
  • FDMT has a higher upside potential (average analyst target price relative to current price) than 2024.49% of stocks in the small market cap category.

Stocks similar to 4D MOLECULAR THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CGEM, SABS, and VOR.

Is FDMT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!